Breast Reconstruction Market by Type (Bilateral, Unilateral), Product (Acellular Dermal Matrices, Breast Implants, Tissue Expanders), End-User - Global Forecast 2023-2030

Breast Reconstruction Market by Type (Bilateral, Unilateral), Product (Acellular Dermal Matrices, Breast Implants, Tissue Expanders), End-User - Global Forecast 2023-2030


The Breast Reconstruction Market is projected to reach USD 3.43 billion by 2030 from USD 1.83 billion in 2022, at a CAGR of 8.15% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Breast Reconstruction Market.
  • Based on Type, market is studied across Bilateral and Unilateral. The Unilateral is projected to witness significant market share during forecast period.
  • Based on Product, market is studied across Acellular Dermal Matrices, Breast Implants, and Tissue Expanders. The Breast Implants is further studied across Saline Breast Implants and Silicone Breast Implants. The Breast Implants is projected to witness significant market share during forecast period.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Clinics & Hospitals. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Breast Reconstruction Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Breast Reconstruction Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Breast Reconstruction Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., BELLASENO GmbH, Cerecare SAS, Deutsche Beteiligungs AG, Establishment Labs Holdings, Inc., GC Aesthetics France SAS, Groupe Sebbin SAS, Guangzhou Wanhe Plastic Material Co.,Ltd, Hans Biomed Co., Ltd., Ideal Implant Incorporated, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Laboratoires Arion, Lattice Medical SAS, Polytech Health & Aesthetics GmbH by Deutsche Beteiligungs AG, and Sientra, Inc..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Breast Reconstruction Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Breast Reconstruction Market?
  3. What is the competitive strategic window for identifying opportunities in the Breast Reconstruction Market?
  4. What are the latest technology trends and regulatory frameworks in the Breast Reconstruction Market?
  5. What is the market share of the leading vendors in the Breast Reconstruction Market?
  6. Which modes and strategic moves are suitable for entering the Breast Reconstruction Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Breast Reconstruction Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing medically reported incidences of breast cancer and mastectomy
5.1.1.2. Increasing awareness about breast reconstruction
5.1.1.3. Favorable reimbursements for breast reconstruction
5.1.2. Restraints
5.1.2.1. Strict clinical practice guidelines for post-mastectomy breast reconstruction
5.1.3. Opportunities
5.1.3.1. Development of 3D-printed implants
5.1.3.2. Ongoing research & development regarding breast reconstruction
5.1.4. Challenges
5.1.4.1. Long term effects of breast reconstruction and issues related to product recalls
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Breast Reconstruction Market, by Type
6.1. Introduction
6.2. Bilateral
6.3. Unilateral
7. Breast Reconstruction Market, by Product
7.1. Introduction
7.2. Acellular Dermal Matrices
7.3. Breast Implants
7.4.1. Saline Breast Implants
7.4.2. Silicone Breast Implants
7.4. Tissue Expanders
8. Breast Reconstruction Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Clinics & Hospitals
9. Americas Breast Reconstruction Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Breast Reconstruction Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Breast Reconstruction Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. BELLASENO GmbH
13.1.3. Cerecare SAS
13.1.4. Deutsche Beteiligungs AG
13.1.5. Establishment Labs Holdings, Inc.
13.1.6. GC Aesthetics France SAS
13.1.7. Groupe Sebbin SAS
13.1.8. Guangzhou Wanhe Plastic Material Co.,Ltd
13.1.9. Hans Biomed Co., Ltd.
13.1.10. Ideal Implant Incorporated
13.1.11. Integra LifeSciences Corporation
13.1.12. Johnson & Johnson Services, Inc.
13.1.13. Laboratoires Arion
13.1.14. Lattice Medical SAS
13.1.15. Polytech Health & Aesthetics GmbH by Deutsche Beteiligungs AG
13.1.16. Sientra, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings